Navigation Links
Mast Therapeutics Engages ESC Advisors To Identify Partnering Opportunities For MST-188
Date:3/28/2013

cy (endothelial dysfunction and/or impaired blood flow). 

The Company is recruiting subjects in EPIC, a pivotal phase 3 study of MST-188 in sickle cell disease. The Company plans to initiate a phase 2 clinical study of MST-188 in acute limb ischemia, a complication of peripheral arterial disease, in late 2013 or early 2014.  More information can be found on the Company's web site at www.masttherapeutics.com.  

Forward-Looking Statements
Mast Therapeutics cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that are based on the Company's current expectations and assumptions. Such forward-looking statements include, but are not limited to, statements regarding anticipated levels of interest in MST-188 among potential strategic partners in and outside of the U.S., the Company's and its advisors' focus and ability to capitalize on any such interest, prospects for MST-188's clinical, regulatory and commercial success in sickle cell disease and other indications, and the potential benefits of partnering MST-188.  Among the factors that could cause or contribute to material differences between the Company's actual results and expectations indicated by the forward-looking statements are risks and uncertainties that include, but are not limited to: the potential for interest in MST-188 among potential strategic partners to be less than anticipated by the Company; the risk that acceptable partnering opportunities for MST-188 may not be available in particular jurisdictions or indications on a timely basis or at all and, consequently, the Company may not be able to pursue development of MST-188 in certain jurisdictions or indications; the potential that partnering transactions involving MST-188 may not advance its development in other jurisdictions, enhance the overall commercial opportunity of the
'/>"/>

SOURCE Mast Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics Secures $15 Million Loan Financing Agreement
2. United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA
3. DART Therapeutics Develops Drug Candidate for Duchenne Muscular Dystrophy
4. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
5. Research and Markets Announces the Release of Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
6. Mast Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results
7. Echo Therapeutics Achieves ISO 13485 Certification
8. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
9. Echo Therapeutics Appoints Robert Doman to Board of Directors
10. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
11. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  Cardinal Health has been ... for Executive Women " by the National Association for ... and promote successful women. "We,re counting ... top companies and are happy to find that companies ... Spence , NAFE President. "The 2015 NAFE Top Companies ...
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research ... announced the addition of SNS Research,s new report ... - Opportunities, Challenges, Strategies & Forecasts" to ... drug is a pharmaceutical product, usually intended to ... manufactured without a license from the innovator company ...
(Date:3/3/2015)...  MabVax Therapeutics (OTCQB: MBVX), a cancer diagnostic and immunotherapy ... President and CEO, will be presenting at the 27 th ... 12, 2015 at the Ritz Carlton in Laguna ... scheduled for Wednesday, March 11 th , at 11:30 AM ... the Investor Relations section of the Company,s website at ...
Breaking Medicine Technology:Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE 2Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE 3Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE 4Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 2Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 3Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 4Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 5Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 6
... Mich., June 29, 2011 Perrigo Company (Nasdaq: ... to finalize  the regulatory approvals necessary to complete ... privately-held, Minneapolis-based pharmaceutical manufacturer of generic Rx pharmaceuticals ... Chairman and CEO Joseph C. Papa stated, "We ...
... UBM Canon,s leading brand, Japan Medical Design & Manufacturing Technology ... its new Japanese-language website with enhanced content and functionality at ... users to find the resources and information they are seeking as ... , JMDMT , and CMDM . "We,ve ...
Cached Medicine Technology:Perrigo Provides Update on Acquisition of Paddock Labs 2Perrigo Provides Update on Acquisition of Paddock Labs 3UBM Canon Announces New Japanese-Language Website for Japan Medical Design & Manufacturing Technology: www.jmdmt.com 2
(Date:3/3/2015)... RATON, Fla - (March 3, 2015) (PRWEB) March 03, ... Class Vacations, Inc. (FCV), an innovator in the travel ... step in his trailblazing expansion plan. To fulfill his ... with the addition of 400 fun, exciting and well-compensated ... Florida headquarters and a news sales center planned for ...
(Date:3/3/2015)... 03, 2015 March 3, 2015, My Positive ... episode. The episode was a unique one, not just because ... because it featured two men who were both faced with ... the beginning of the episode, Deierlein said to Collins, “I ... radio show, but I’m very excited that you could join ...
(Date:3/3/2015)... New Zealand and Rockville, Maryland (PRWEB) March 03, ... selected Cornerstone Communications, LTD as its North American ... Cornerstone was awarded the Manuka Lab contract because ... and consumer verticals. , Headquartered in Auckland, New ... company focused on providing clients effective, certified natural ...
(Date:3/3/2015)... 03, 2015 Using an “intelligent,” rather ... Medicare Part D prescription drug coverage plans could save ... new University of Pittsburgh Graduate School of Public Health ... the March issue of the journal Health Affairs and ... have saved more than $5 billion in its Part ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Claflin ... the Department of Veterans Affairs has signed a new, ... March 1, 2015. , Under the contract, the ... such as the U.S. Military, Indian Health Services, National ... local government entities with competitive pricing for hospital equipment ...
Breaking Medicine News(10 mins):Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 2Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 3Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:Manuka Lab North America, Inc. Awards Cornerstone Communications, LTD North American Agency Contract 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 3Health News:Claflin Medical Equipment (CME) Announces New 5 Year Contract with the Department of Veterans Affairs (VA) 2
... dyslexic brain may have problems in forming perception categories for// ... lead to the dyslexics finding it difficult to filter out ... front of them. ,The research by the scientists from ... in the nature of the workings of a dyslexic brain. ...
... by trained health workers can help in early// detection of ... rate. ,A research done by scientists from Kerala, India, ... people for oral cancer in order to provide early medical ... ,Oral cancer is the growth of malignant tissues or ...
... It is possible to lose knee lubrication following an injury ... ,Researchers from University of Rhode Island had identified a ... happened to a knee after a knee injury, in order ... factor for arthritis. ,Although knee injury is considered to ...
... bacterial infections from the bacteria Pseudomonas.// Treatment for ... suggests that antibiotic treatment may encourage the bacteria ... ,Cystic fibrosis is disease of genetic origin ... that affects the lungs and can cause severe ...
... children are more exposed to indoor allergens// at their ... are commonly found indoor include bacteria, molds, mildew, viruses, ... and pollens. These may cause allergic reactions like allergic ... of the symptoms experienced by people in presence of ...
... of chicken pox vaccine to// effectively control the painful condition ... is the condition that gets symptoms of rashes or blisters ... and numbness on the area. There may be fever with ... chicken pox and is caused by the same virus varicella-zoster. ...
Cached Medicine News:
... has been developing diverse medical ... years. Our medical-surgical products have ... innovation, quality and customer satisfaction. ... the Labtron® line of diagnostic ...
... deliver particulate humidity in the 3 to ... patients. For your convenience, Thera-Mist® nebulizers may ... sterile water., ,The P30000N, for normal ... with a total flow range of 68-24 ...
... be held at angles up to 45° without ... spill column, finger grooves for a non-slip gripping ... feet of regular oxygen tubing. The large ... and sustain optimum mist concentration at every setting. ...
With ten colors available, Spectrums line of Color-Coded Fiberoptic Light Cables makes it easy to track by department....
Medicine Products: